In the HYPITAT trial, induction of labour at 37 weeks in women with gestational hypertension or mild pre-eclampsia compared to expectant management resulted in:

• A No difference in adverse maternal outcomes
• B Significant reduction in adverse maternal outcomes but doubled caesarean rate
• C Worse neonatal outcomes in the induction group
• D Significant reduction in adverse maternal outcomes without increasing caesarean rate ✓

Explanation

The HYPITAT trial (Netherlands, 2009) randomised women with gestational hypertension or mild pre-eclampsia at 36–41 weeks to induction vs expectant management. Induction significantly reduced adverse maternal outcomes (progression to severe disease, HELLP, eclampsia) without a significant increase in caesarean section rate. Neonatal outcomes were comparable between groups.

Reference: Williams Obstetrics, 26th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.